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Abstract: Recently, it was shown that the majority of genes linked to human diseases, such as
cancer genes, evolved in two major evolutionary transitions—the emergence of unicellular organisms
and the transition to multicellularity. Therefore, it has been widely accepted that the majority of
disease-related genes has already been present in species distantly related to humans. An original way
of studying human diseases relies on analyzing genes and proteins that cause a certain disease using
model organisms that belong to the evolutionary level at which these genes have emerged. This kind
of approach is supported by the simplicity of the genome/proteome, body plan, and physiology
of such model organisms. It has been established for quite some time that sponges are an ideal
model system for such studies, having a vast variety of genes known to be engaged in sophisticated
processes and signalling pathways associated with higher animals. Sponges are considered to be the
simplest multicellular animals and have changed little during evolution. Therefore, they provide
an insight into the metazoan ancestor genome/proteome features. This review compiles current
knowledge of cancer-related genes/proteins in marine sponges.
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1. Introduction
While cancer evolution is still not fully understood, it is clear that the appearance of
multicellularity is directly related to the origin of this widespread disease. Cancer can be described
as a consequence of errors within the multicellular system causing the proliferation of “selfish” cell
lines [1]. It is most likely that cancer appeared in parallel with multicellularity and the development of
true tissues and organs, and that the genes responsible for cellular cooperation and multicellularity
evolved together. When malfunctioning, these genes may cause cancer [2]. Intensive research in the
field of molecular oncology over the recent decades expanded the initial division of cancer genes to
oncogenes and tumor suppressor genes, by involving genes connected to angiogenesis, differentiation,
adhesion, as well as to invasion processes, inflammation etc. Although little is known about cancer in
invertebrates, especially non-bilaterians and unicellular relatives of animals, the available literature
sources report on tumorous formations in some phyla, for example flatworms, molluscs, and insects [1].
Even some of the simplest “early branching” non-bilaterian animals, such as cnidarians, may develop
tumors [3]. Comparative genomics studies have implied that a number of genes linked to human
diseases were already present in species distantly related to humans [4] and similar has been suggested
for cancer genes [5]. It seems that most of cancer-related protein domains have appeared during the two
main evolutionary peaks, the emergence of unicellular eukaryotes and the transition to multicellular
metazoans [5]. Since no systematic studies were thus far performed to reveal the occurrence of
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tumors in invertebrates, the current knowledge about cancer and status of cancer-related genes in
simple animals is scarce. Studying cancer-related genes at the level at which they have first emerged,
in a simpler model system, may provide an insight into their basic cellular functions.
The sponges (phylum Porifera) are the simplest and likely the most ancient group of animals
that have separated from other metazoans more than 800 million years ago [6]. They are sessile
as adults and lack true tissues and organs as well as any recognizable sensory or nerve structures.
Despite their simple morphology, sponges genomes are complex [7] and many of their genes bear
a striking similarity to vertebrate homologs [8]. Should we postulate that tumors had developed
together with the emergence of tissues and organs, it would be likely for sponges to be unable to
form tumors. Their genomes nevertheless, contain the majority of genes whose human homologs are
implicated in cancer [7]. Research of cancer associated genes in simple animals with no tissues and
blood vessels, such as sponges, could help in understanding the more complex signalling circuitry
of their homologs in higher animals, such as vertebrates. Although comparative genomics studies
have shown that many genes linked to cancer diseases in humans were already present in marine
sponges [5,8], a precise understanding of their status and especially their biochemical and biological
functions in sponges is more than limited.
Herein, we review the current knowledge on cancer-related genes/proteins in marine sponges
(Figure 1) as well as the available experimental data about their biochemical characteristics and
functions. Although genes/proteins are roughly divided according to their most prominent function,
most of them are known to be involved in several cancer-causing processes.
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been described in sponges (Porifera). First and foremost are protein kinases, which, among various
signalling pathways, also control cell proliferation [10].
2.1. Protein Kinases
The protein kinase family encompasses enzymes that catalyse transfer of the phosphate
group from a high energy molecule such as adenosine triphosphate (ATP) to a specific substrate.
Protein kinases play a significant role in cell-life regulation: in signal transmission pathways,
cell differentiation control, proliferation, metabolism, DNA damage repair, cell motility, response to
external stimuli, and apoptosis. Mutations, or other genetic alterations causing changes in their activity,
often result in malignant transformation.
Protein kinase C. Protein kinase C (PKC) is a class of serine/threonine kinases which represents
one of the most studied signaling kinases [11]. Although the expression of PKCs is changed in
multiple cancer types, their diverse biological functions make it difficult to define the relationship
between these changes and the initiation of a disease. Analysis of the gene coding for PKC in the
sponge Geodia cydonium showed that it contains 13 exons and 12 introns and that exons encode the
regulatory and catalytic domains typical for the metazoan PKCs. Further analysis of the promoter
activity revealed that this, phylogenetically oldest, PKC gene contains a promoter functional in the
heterologous mammalian cell system [12]. It was shown that sponge aggregation factor (AF) functions
not only as a cell adhesion molecule, but also as a mitogenic agent [13]. In this context, PKC is involved
in the AF induced transmembrane signalling. The activation of PKC leads to phosphorylation of
many nuclear components, including the topoisomerase II, which subsequently activates the DNA
replication process [14]. Two PKCs, GCPKC1 and GCPKC2, have been sequenced from G. cydonium [15].
A comparison of the complete structures of the sponge PKCs, with those of higher metazoans, but also
of protozoan, plant, and bacterial Ser/Thr kinases, revealed that the animal kinase domains display
homologies with those from plants, protozoa, and bacteria. This implies that the Ser/Thr kinase
domain has an universal common ancestor. However, the overall structure of the metazoan PKCs
differs from non-metazoans, which suggests their distinct functions [15].
2.2. Protein Tyrosine Kinases
Protein tyrosine kinases (PTKs) specifically phosphorylate tyrosines on their target proteins.
According to their cellular localization PTKs are divided in two major categories: receptor PTKs or
transmembrane proteins (RTKs) and non-receptor or cytoplasmic PTKs. They are almost exclusively
found in Metazoa and many have been described in sponges [16–21].
The receptor tyrosine kinase. The phylogenetic analysis of the protein-serine/threonine kinases
(PS/TKs) from three sponges, the demosponges G. cydonium and Suberites domuncula and the calcareous
sponge Sycon raphanus, suggests a common ancestry of PTKs with the PS/TK superfamily, from which
the G. cydonium RTKs have diverged first [22]. The analysis of the G. cydonium RTK gene revealed
that it contains introns outside of its TK domain, unlike the introns in higher animals that are inserted
into the TK region [23]. Since the RTK from G. cydonium has been identified as the phylogenetically
oldest member of PTKs [24], it was assumed that introns within the TK domains of genes from higher
animals were inserted after the sponge taxa have branched off from all other metazoans [23].
The FES/FER non-receptor tyrosine kinases. Two different forms of Feline Sarcoma and FES
Related proteins (FES/FER) exist in mammals [25] and both can be activated by a number of
extracellular signals [26]. FER/FES non-RTKs are engaged in cytoskeletal rearrangements, as well
as in cell-matrix and cell-cell interactions, while genetic analyses implicate their involvement in the
regulation of inflammation and innate immunity [27]. The implication of FES and FER in human
pathology still remains to be fully elucidated, but their high oncogenic potential has been implied in
several recent studies [28,29]. The analysis of cDNA from the sponge S. raphanus disclosed a protein
highly similar in its primary structure and organization of domains with tyrosine kinases (TKs) from
the FES/FER family of non-RTKs [18]. The protein from S. raphanus was named FES/FER_SR since
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it exhibited high homology to the mammalian FES/FER proteins. Phylogenetic analysis revealed
that FES/FER_SR from S. raphanus is the most ancient known member of the FES/FER family of
non-RTKs [18]. Their role in organisms without tissues and organs, such as sponges, is not yet clear.
The SRC non-receptor tyrosine kinases. SRC (Rous sarcoma oncogene cellular homolog) is
a non-receptor PTK that has been implicated in the development of malignant tumors in humans [30].
SRC is involved in many signaling pathways, such as gene transcription, cell cycle progression,
cell adhesion, apoptosis, transformation, and migration. An extensive analysis of SRC PTKs from the
marine sponge S. domuncula revealed nine different cDNAs encoding three different SRC proteins,
SRC1SD, SRC2SD, and SRC3SD [16]. Considering that the N-termini of each of these proteins are
unique, it can be speculated that the three sponge SRC kinases have different biological functions.
Furthermore, it seems that all three SRCs from S. domuncula display the highest homology with SRCA
PTKs from higher Metazoa. Phylogenetic analysis showed that SRC-related Src Homology 2 and 3
(SH2 and SH3) domains from different species are more conserved than SH2 and SH3 domains within
different S. domuncula proteins [16]. The described data suggests that src genes are very ancient, that
they already existed in the common ancestor of all Metazoa and that the ancestral src gene was already
a multidomain protein composed of SH3, SH2 and tyrosine kinase (TK) domains.
Bruton’s tyrosine kinase. Bruton’s tyrosine kinase (BTK) belongs to the TEC (Tec Protein Tyrosine
Kinase) family of PTKs and is required for maturation of the b-lineage lymphoid cells. Mutations in
the BTK gene were shown to cause X-linked agammaglobulinemia (XLA) in humans and X-linked
immunodeficiency (Xid) in mice [31,32]. Poriferan BTK-like protein (BTKSD) has been described from
the marine sponge S. domuncula. This 700-aa-long protein contains all typical TEC family domains and
shows the highest homology with the human BTK protein [17]. Phylogenetic analysis of PTKs from
the TEC family revealed that the BTK/TEC genes have an ancient origin and have remained highly
conserved during evolution [33]. These genes have probably been present in the common ancestor
of all metazoans before gene duplications and the separation of sponges from other animal lineages.
The structural analysis of the sponge and human promoter implies similar regulation of both genes;
the kinase activities of the sponge BTKSD enzyme and its human homolog are in the same range [33].
Therefore, it is reasonable to presume that the ancestral-type protein was structurally and functionally
similar to the multifunctional enzyme present in higher animals. Given that the BTK function in
mammals is associates with the modulation of actin polymerization, a similar role of BTK-like protein
in sponges is also expected. Modulation of actin polymerization by TEC family kinases probably
has a significant role in cellular processes such as proliferation, motility, and adhesion [34]. Further,
it was shown that PTKs of the TEC family possess a key role in production of the lipopolysaccharide
(LPS)-induced tumor necrosis factor involved in the cellular response to bacterial infections [35].
Since S. domuncula is very efficient in fighting bacterial infections [36], it is possible that the role of BTK
in sponges also includes antimicrobial defence.
Cyclins, cyclin-dependent kinases, and other key proliferation molecules. Cyclin-dependent
kinases (CDKs) are a group of serine/threonine kinases, critical in the regulation of the cell cycle [37].
A comprehensive evolutionary study of cyclins and CDKs in metazoans and their unicellular relatives
has been published by Lihuan Cao et al. [38]. It seems that the sponge genome lacks three cyclin
subfamilies, cyclin A, cyclin D, and cyclin O, while the CDK4/6 subfamily is also missing from its
genome. Although it has already been present in the placozoan Trichoplax adhaerens, the authors
speculate that the establishment of the CDK4/6-cyclin D complex may have been fully functional in
cell cycle control during eumetazoan emergence.
Finally, it seems that p53 (tumor protein p53), the guardian of the genome and putative tumor
suppressor gene, is also present in the sponge genome as well as the powerful MYC (myelocytomatosis
oncogene cellular homolog) and RAS (Rat sarcoma) oncogenes [7,39]. It has even been reported that
the choanoflagellate Monosiga brevicollis already contains a subset of transcription factors, such as
p53 and MYC, previously thought to be specific for metazoans [40]. The evolutionary history of p53
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gene family as well as MYC [41] has been studied, but not specifically in the sponge genome [42].
The RAS-like family of proteins will be discussed further in the text.
3. Players in Cellular Senescence and Apoptosis
It is widely accepted that normal cells are able to pass only through a limited number of divisions.
The unlimited proliferation of cancer cells has been associated with impairment of two major cellular
cancer defence mechanisms: senescence and crisis/apoptosis. Senescence is normally a consequence of
shortening of telomeres, multiple tandem hexanucleotide repeats that protect the ends of chromosomes
from end-to-end fusion. The progressive shortening of telomeres can be stopped by telomerase,
which can add repetitive nucleotide sequences to the ends of chromosomes [43]. In eukaryotic cells the
telomere activity is usually restricted to germ and stem cells. In all other normal cells after a limited
number of divisions the cell enters a senescent, but viable state. If the cell breaks this barrier, the crisis
occurs which immediately redirects the cell to engage in the apoptotic program. The rare event of
cellular immortalization of potential cancer cells occurs by the knock-down of both of these barriers.
This is usually due to unlocking the transcriptional program which leads to dedifferentiation followed
by upregulating of telomerase expression [9].
As expected, telomeres are an integral part of sponge chromosomes. The telomere sequence
has been analyzed in three different sponge species and it consists exclusively of (TTAGGG) n-type
sequences that are widely distributed in many multicellular animals belonging to the various phyla
and classes [44]. The telomerase activity was determined in two different sponges: S. domuncula
and G. cydonium [45]. A quantitative analysis revealed that tissues from both sponges contained
telomerase activity of approximately 30% and 20%, respectively, of the activity in the positive
reference cells. In higher animals the high telomerase activity is strictly limited to germ cells and
metastatic tumors, while stem cells, needed for tissue renewal and injury repair, have intrinsically
low levels of telomerase [46]. It is known that sponge tissue has a very low germ cell number, so this
finding may indicate that all of the sponge cells have some, low telomerase level and, therefore,
maintain permanently their proliferation potential. The isolated sponge cell in cell culture, however,
stops proliferating [47] and loses the telomerase activity, opposed to the human tumor cells, which in
culture conditions obtain both proliferation and telomerase activity. All these findings indicate that
sponges have already developed the senescence/apoptotic program.
Apoptosis is a form of programmed cell death which can be found in multicellular metazoans and is
a necessary prerequisite for the optimal functioning of these organisms. Apoptosis is a highly controlled
mechanism which serves to eliminate redundant, infected, necrotic, or simply unwanted cells during
development, senescence, morphogenesis, organogenesis, and defence, or other physiological and
pathophysiological events [48]. In multicellular organisms apoptosis serves as a major barrier against
uncontrolled proliferation, which leads to cancer. The apoptotic process can generally be divided
into two pathways. The extrinsic pathway is triggered upon ligation of tumor necrosis factors (TNFs)
transmitting the apoptotic signal into the cell. The intrinsic pathway is stress-dependent and controlled
by members of the Bcl-2 protein family. Both pathways culminate with the activation of proteolytic
enzymes, caspases, the executors of programmed cell death.
It seems that the sponge genome possesses components of both pathways. Experimental evidence
proves that marine sponges, like G. cydonium or S. domuncula, undergo the process of apoptosis during
formation of asexual reproduction bodies or in stress response [49]. The poriferan pro-apoptotic
molecule DD2 (death domain 2), a death domain containing molecule, was identified by screening
G. cydonium library with degenerate primers directed towards a conserved region of human FAS
receptor (fas cell surface death receptor). Interestingly, this protein has two death domains which have
not been found in any known protein involved in the TNF signalling pathway.
Moreover, evolutionary ancient members of the intrinsic, Bcl-2 (B-cell lymphoma 2) family
members have been identified in sponge [50]. The sponge G. cydonium expresses a pro-survival
Bcl-2 homolog BHP2 that impairs apoptosis in sponge tissue induced by heat shock or tributyltin
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exposure [51]. Recently, Caria et al. [52] performed structural and binding studies on BHP2 and
BAK-2 (Bcl-2 Antagonist/Killer) from G. cydonium and the freshwater sponge Lubomirskia baicalensis.
The results of their findings suggest that the molecular machinery and mechanisms for executing
Bcl-2-mediated apoptosis are evolutionary ancient and resemble their mammalian versions.
Furthermore, FAU (Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously
expressed), recently identified as a pro-apoptotic regulatory gene mediated by Bcl-G (a pro-apoptotic
member of the Bcl-2 family), has also been identified in the sponge genome [53]. FAU gene encodes
a fusion protein composed of an ubiquitin-like protein (FUBI) at its N terminus and ribosomal
protein S30 at the C terminus. The protein is then post-translationally processed into two separate
proteins, FUBI and S30 ribosomal protein. FAU has been identified as a pro-apoptotic regulatory gene,
whose expression has been downregulated in human ovarian, prostate, and breast cancer [54–56].
A study of the FAU protein from the marine sponge S. domuncula showed that sponge FAU protein
displays a pro-apoptotic activity, as it increases apoptosis in human HEK293T cells (human embryonic
kidney cells) as well as its human homolog and was shown to be more similar to its human homolog
than to the one from Caenorhabditis elegans or Drosophila melanogaster. These findings implicate that the
common metazoan ancestor probably possessed the FAU protein that was structurally and functionally
similar to its recent version and has changed very little during evolution [57]. Additionally, the number,
phases, and position of its introns were not significantly changed from sponges to humans. Ribosomal
proteins (RPs) are evolutionary conserved components of ribosomes crucial for the correct ribosome
assembly. Many ribosomal protein genes (RPGs) have additional extraribosomal functions, being
involved in replication, regulation of cell growth, apoptosis, and cancer development [58]. RPs have
shown to be important tools for studying intron evolution, since the analysis of RPG introns in
sponges revealed the same rate of conservancy between two different sponge species compared to the
conservancy between sponges and humans [59,60]. Since S30 ribosomal protein is produced from the
fusion protein transcribed from the pro-apoptotic regulatory gene FAU, its extraribosomal function
may be connected to the regulation of apoptosis [57].
As mentioned above, the apoptotic process is eventually executed by specific proteases, caspases.
According to Wiens et al. [49], altogether three caspase-like proteins have been found in Porifera.
The smaller number of caspase family genes, compared to vertebrates, probably implies the simplicity
of this proteolytic cascade in sponges, but undoubtedly suggests that this process was already present
and engaged in first simple multicellular animals.
4. Cell Anchoring Molecules
Adhesion of cells is a primary prerequisite for tissues architecture. Cell within tissues adhere to
each other, as well as to the extracellular matrix (ECM); these connections are collectively called
the anchoring junctions. Several types of anchoring junctions have been identified, depending
on the type of adhesion, and they are in general responsible not only for anchoring cells within
a certain tissue, but also for their migration. Anchoring junctions are multiprotein complexes in which
cell-adhesion molecules (CAMs) play a crucial role. There are five principal classes of CAMs: cadherins,
immunoglobulin (Ig) superfamily, selectins, mucins, and integrins. Integrins mediate cell-matrix
interactions whereas other types of CAMs participate in cell–cell adhesion [61]. Cell adhesion is
essential in all aspects of vertebrate cell growth, migration, and differentiation. CAMs are involved
in a wide variety of cellular functions including signal transduction, cellular communication and
recognition, embryogenesis, inflammatory and immune responses, and apoptosis [62], therefore,
they play a significant role in cancer progression and metastasis. For example, tumor invasion and
metastasis frequently coincide with the loss of E-cadherin-mediated cell–cell adhesion [63].
During the last century sponges have been repeatedly used as a model system for studying cell
adhesion [26,64]. The first extracellular particle named aggregation factor (AF), which promotes
the species-specific aggregation of sponge cells, was isolated from two sponges in 1973 [65,66].
The G. cydonium AF was shown to bind the plasma membrane-bound aggregation receptor (AR),
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after which the RAS gene is expressed [67]. The RAS gene product further binds to the anti-aggregation
receptor (aAR), which has been identified as a lectin receptor [68,69]. After the first cell–cell adhesion
molecule, galectin [70], and the first cell–matrix adhesion receptor, integrin [71,72], were identified in
sponge G. cydonium, it became clear that sponges contain proteins involved in adhesion, which also
show homology to those in humans [73]. The extracellular matrix (ECM) represents a platform
for cell adhesion via integrin receptors, signal transduction, cell development, and cell division.
Sponge mesohyl, a space between the external pinacoderm and the internal choanoderm, is composed
of collagen, fibronectin-like molecules, and dermatopontin [74], which are also found in the ECM
of higher metazoans. Therefore, it seems that the sponge mesohyl could serve as a primitive ECM
in sponges.
Cadherins. Cadherins (CDHs) are a major component of adherent junctions, typically present
in vertebrate epithelial tissues. Adherent junctions are composed primarily of type I cadherins,
transmembrane glycoproteins that form Ca+2-dependent homotypic complexes. Loss of cadherins
enables cancer cells to detach from the original tissue and trigger the metastatic cascade. It is widely
accepted that the key molecule in metastasis onset is E-cadherin, specifically. Cadherins (CDHs)
and cadherin-related proteins are found in the genomes of all sequenced metazoans, including
diverse bilaterians, cnidarians, sponges, and also in choanoflagellates, the closest unicellular relatives
of animals [75]. CDH1 and CDH2 (type I) are found to be involved in metastasis suppression.
Nichols et al. [76] have described the incomplete type I CDH1 from the draft genome of sponge
Oscarella carmela.
Integrins. Integrins form a large family of cell adhesion receptors involved in cell adhesion,
migration, and signalling [77]. Integrins are heterodimers composed of one α and one β subunit.
Eighteen different integrin α subunits and eight β subunits have been described [78].
All animals express integrins, indicating that this family evolved early in the history of
metazoans. Both α and β subunits have been found throughout the invertebrates species, including
sponges [71,72,79].
5. Metastasis Suppressor Genes
Metastasis is a process in which tumor cells detach from the original tissue, travel to nearby or
distant sites in the body and form secondary tumors. Metastasis suppressors inhibit the tumor cell
ability to metastasize, having little or no effect on the primary tumor growth. Metastasis suppressors
are involved in one or several steps of the metastatic cascade, which includes the following: detachment
of the cell from the main tissue, breaking through the basal lamina and invasion of the surrounding
tissue, entrance to the nearby blood or lymphatic vessels, surviving the transit through the lymphatic
or blood system and extravasation from blood/lymphatic vessels into the distant tissue, where they
can grow into macroscopic tumors [80]. The ongoing discoveries of genes/proteins that are directly
involved in the metastatic cascade seem to be an important step forward in our understanding of
this process.
NME1. The human NME1 (non-metastatic 1) is the first identified and the most studied
metastasis suppressor [81], present in all three domains of life: Bacteria, Archaea, and Eukarya [82].
The NME1 protein possesses the nucleoside diphosphate kinase (NDPK) activity, but also has
some additional functions such as histidine kinase activity, transcription factor activity, etc. [83,84].
A single gene coding for the human NME1 homolog was found in the genome of the marine sponge
Amphimedon queenslandica [7] and S. domuncula cDNAs [8,85]. These sponge homologs are similar
in primary structure and possess conserved residues essential for NDPK activity. Biochemical and
functional characterizations of non-bilaterian homologs of the human NME1 protein are still scarce.
Our group has shown that sponge genes NMEGp1 are intron-rich and that these introns are relatively
short. The analysis of sponge NMEGp1 promoters showed that some of the motifs crucial for human
promoter activity are also present in sponges. Furthermore, the analysis of protein activity showed
that the sponge S. domuncula NMEGp1Sd protein possesses a hexameric form and has a similar
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level of kinase activity as the human NME1 protein. The sponge homolog interacts with its human
ortholog/homolog in human cultured cells and shows the same subcellular localization pattern as
human NME1. Also, if expressed in human tumor cells, the sponge homolog significantly reduces
its migration potential. Based on the evidence presented, we have concluded that the sponge NME
protein can replace its human homolog in at least some of its biological functions which are usually
associated with “higher” metazoans. We also presumed that the biochemical function of NME1,
which is responsible for metastasis suppression in human, is present in the sponge, and was possibly
also present in the ancestor of all Metazoa [86,87]. On the contrary, our studies on another member
of the NME family in sponges, NME6, indicates that this ancient gene/protein probably changed its
biochemical/biological function during the course of evolution. It is not yet elucidated whether this
protein is also linked to tumor formation or progression [88].
Small GTPases. RAS-like superfamily of GTPases (small GTPases) are a family of enzymes that
bind and/or hydrolyze GTP. The state of the bound nucleotide acts as a switch between the active and
inactive state of the enzyme. The RAS superfamily is divided into five subfamilies: RAS, RHO, RAN
(Ras-related nuclear protein), RAB (Ras genes from rat brain), and ARF (ADP ribosylation Factor) [89].
Small GTPases play an important part in numerous cellular processes but it is generally accepted
that the RAS family is responsible for cell proliferation, RHO for cell morphology, RAN for nuclear
transport, and RAB and ARF families for vesicle transport. Therefore, it is clear that the RAS-like
superfamily is implicated in several aspects of cancer occurrence and progression [90]. The analysis
of the EST database from the marine sponge S. domuncula has revealed cDNA sequences encoding
50 different RAS-like small GTPases. Forty-four sponge proteins from the RAS family are described
here: six proteins from the RAS subfamily, five from RHO, six from ARF, one RAN, and 26 RABs
or RAB-like proteins. Small GTPases from sponge are more related in their primary structure to
the orthologues from vertebrates than to those from other invertebrates. These findings imply that
diversification of genes encoding RAS-like small GTPases happened after the duplications that occurred
very early in the evolution of Metazoa [39].
6. Cancer Associated Genes in Marine Sponges-Final Remarks and Future Challenges
Apart from humans, tumors have mostly been described in other vertebrates, especially in farm
animals and pets, as well as in other animals kept in captivity [1]. Furthermore, they have also been
reported in invertebrate deuterostomes [1], protostomes [80,91], and even in simple non-bilaterian
animals [3,92,93], although these findings should be taken with caution since laboratory breeding and
culture conditions may be far from those found in their natural habitats [3]. Therefore, it is doubtful
whether these organisms would develop tumors also in a natural environment. Indirect evidence of the
presence of tumors in simple non-bilaterian animals also comes from the fact that marine invertebrates,
especially sponges, produce bioactive compounds [94], some of which have an antitumor activity on
human cells in culture [95–97]. The role of these compounds in sponge biology is not fully understood.
Since, sponges are sessile and lack capabilities for physical defences, they are often targets of marine
predators. Therefore, it is expected that sponges have developed a range of defensive chemicals in
order to disable and repel predators. They also use their defensive substances to keep plants and
other animals’ offsprings from settling onto their surface [98,99]. Although it is widely accepted that
sponges use these compounds for ecological purposes it cannot be excluded that at least some of these
substances, are used in physiological processes, e.g., as a primitive form of immunological defence,
in the regulation of cell count or for various metabolic purposes. Some of the compounds they produce
are directly engaged in specific signalling pathways. However, it should be taken into consideration
that more than one pathway is usually affected by each of those compounds.
About a hundred novel compounds that exhibit significant inhibitory activity towards
a range of protein kinases have been detected so far [100]. Some of these act as inhibitors of
protein kinase C (PKC): xestocyclamine A [101] (Z)-Axinohydantoin), debromo-Z-axinohydantoin,
hymenialdisine, debromohymenialdisine [102], frondosins A–E [103], BRS1 (C30 BIS-Amino,
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BIS-Hydroxy polyunsaturated lipid) [104], sesquiterpenoid quinones, nakijiquinones A–D [105,106],
cytotoxic sesterpenes spongianolides A–E [107], lasonolide A [108–110], azetidine compound
penazetidine A [111], and numerous others. Several compounds that display inhibitory activity
towards CDKs have also been isolated from marine sponges, such as hymenialdisine [112,113],
microxine, variolin B [114,115], fascaplysin [116], and konbu’acidin A [117]. It has also been
shown that marine sponges possess tyrosine protein kinase (TPK) inhibitors: the penta-, hexa-
and hepta-prenylhydroquinone 4-sulfates [118], melemeleone [119], and polyketide inhibitors [120].
Furthermore, (+)-aeroplysinin-1 from sponge displays a strong antitumor effect by blocking
the proliferation of EGFR-dependent human breast cancer cell lines MCF-7 and ZR-75-1 [121],
while curcuphenol displays a SRC protein kinase inhibition and curcudiola focal adhesion kinase
(FAK) inhibition [122].
So far, as much as 60 compounds isolated from marine sponges have been shown to induce
anticancer activity through apoptosis. For the majority of them, the proapoptotic mechanism has
not yet been fully elucidated [123]. The pre-clinical study on Renieramycin M reveals that this
substance induces apoptosis in cancer cell lines through the p53-dependent pathway and consequently
inhibits cancer progression and metastasis [96]. Renieramycin M, a tetrahydroisoquinoline,
is the first anticancer drug to be approved by the European Union and by the Food and Drug
Administration (FDA) for the treatment of advanced soft tissue sarcomas [124]. Selected compounds
for which cellular and molecular mechanisms were explored in depth include: aaptamines [125],
psammaplysene A (PsA) [126], stellettin B [127–129], candidaspongiolide [130], heteronemin [131–133],
and dideoxypetrosynol A [134]. Many compounds produced by marine sponges display antiproliferative
activity targeting various signaling pathways of the cell-cycle progression such as aragusterol A [135],
(19Z)-hlichondramide [136], smenospongine [137], and crambescidin 800 [138]. Some can also act
as anti-inflammatory molecules targeting TLR (Toll-like receptor) signalling pathways [139], or as
inhibitors of matrix proteinases [140]. Further, it has been shown that macrolide halichondramide
(HCA) has an antimetastatic effect on human prostate cancer cells PC3, inhibiting their migration
and invasion through the modulation of the crucial cadherin switches [141]. The specific role of these
substances in sponge ecology and metabolism will hopefully be disclosed by future studies.
Based on the data collected so far, we can only speculate on the presence of cancer during the early
animal evolution. It is presumed that tumors in invertebrates do not exhibit a malignant phenotype,
while the progress in malignancy probably runs in parallel with the development of the immune
system [142], as well as the development of a highly effective vasculatory system in vertebrates [143].
Despite the lack of true organs and tissues in sponges, they obviously possess a number of
genes/proteins related to tumor onset and progression. Their genomes contain many gene homologs
of those involved in human cancer development. Furthermore, the majority of sponge proteins
transcribed from these genes possess the same domain organization as their homologs from higher
metazoans, yet, their function within the sponge cells remains to be elucidated. Tumors in sponges
have not been identified so far and, because of its simple structure, the formation of tumors within
the sponge body is highly unlikely. Nevertheless, a number of studies indicated that sponge proteins
may reflect at least some of the biochemical characteristics related to their homologs in higher animals,
particularly humans. We know today that several other physiological processes are linked to tumor
emergence, such as angiogenesis, inflammation, or cellular energetics [9]. Evidence shows that at least
some of the components involved in these processes are present in sponges, but no systematic research
is done in this context [7,144].
Sponges represent an important model, not only for studying ancestral metazoan homologs and
their features before the diversification and specialization of these genes in higher animals, but also for
understanding the basic physiological function of cancer genes in simpler animals. These findings
could help to elucidate the more complex interactions of their homologs in humans and consequently
explain possible reasons for their oncogenic potential.
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